Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 10 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Uterine Cervical Dysplasia 3 Glioma 3 Colonic Neoplasms 3 Carcinoma, Renal Cell 3 Brain Neoplasms 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Rectal Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Oropharyngeal Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Ependymoma 2 Uveal Melanoma 1 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Ureteral Neoplasms 1 Thyroid Nodule 1

Interventions

Cyclophosphamide 52 Vincristine 32 blinatumomab 30 Prednisone 27 Methotrexate 27 Cytarabine 25 Dexamethasone 23 Specimen Handling 21 Rituximab 20 Doxorubicin 19 merphos 18 Mercaptopurine 18 Etoposide 18 fludarabine 17 Biopsy 17 prednylidene 16 deltacortene 16 N,N-dicyclohexyl-isoborneol-10-sulfonamide 16 Calcium Dobesilate 16 dexamethasone acetate 15 dexamethasone 21-phosphate 15 auricularum 15 Inotuzumab Ozogamicin 15 pegaspargase 14 azathiopurine 14 venetoclax 13 Asparaginase 13 Spinal Puncture 12 Leucovorin 12 CT-P10 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Burkitt Lymphoma × Watchful Waiting × 1 year × Clear all

NCT04425421 2026-03-02

GFALMB2019

French Africa Pediatric Oncology Group

Burkitt Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡